Literature DB >> 6257377

Histology, ultrastructure, and tissue culture of human insulinomas.

T Akagi, Y Fujii.   

Abstract

Four cases of insulinoma were studied by electron microscopy. Insulinoma cells were also cultured in vitro. Ultrastructure was correlated with the content of immunoreactive insulin (IRI) and the percentage of proinsulin-like component (PLC) in the serum, tumors, and culture fluid. The number and shape of secretory granules varied amont the samples, from the tumors having typical beta granules to poorly granulated tumors having a few atypical granules. High levels of IRI in the serum and a high percentage of PLC in the serum and tumor, found in a patient with a virtually agranular tumor, combined with the fact of rare occurrence of emiocytosis, suggest a defective insulin storage mechanism and alternative routes of insulin release in insulinoma cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257377     DOI: 10.1002/1097-0142(19810115)47:2<417::aid-cncr2820470233>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Cell culture and in vitro studies of fresh and cryopreserved human insulinoma.

Authors:  A W Saxe; J W Yoon; P Gorden; M F Brennan
Journal:  In Vitro       Date:  1982-10

2.  Response of human insulinoma cells to extracellular calcium is different from normal B cells.

Authors:  M Kato; R Doi; M Imamura; N Okada; Y Shimada; R Hosotani; J I Miyazaki
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Electron microscope localisation of insulin-like immunoreactivity of conventionally processed human insulinomas.

Authors:  G Berger; F Berger; N Dutrieux; M H Guillaud; J L Vauzelle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

4.  Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995.

Authors:  R Oosterom; T Verleun; P Uitterlinden; H A Bruining; G J Bruining; L Verschoor; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.